Publications - 'S'
Publications 51 - 75 de 2428
| Titre | DOI |
|---|---|
|
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients M. Khellaf; A. Charles-Nelson; O. Fain; L. Terriou; J.F. Viallard; S. Cheze; J. Graveleau; B. Slama; S. Audia; M. Ebbo; G. Le Guenno; M. Cliquennois; G. Salles; C. Bonmati; F. Teillet; L. Galicier; A. Hot; O. Lambotte; F. Lefrere; S. Sacko; D.Kilendo Kengue; P. Bierling; F. Roudot-Thoraval; M. Michel; B. Godeau 2014 |
10.1182/blood-2014-06-582346 |
|
SAFETY AND EFFICACY OF THE COMBINATION DACLATASVIR-SOFOSBUVIR IN HCV GENOTYPE 1-MONO-INFECTED PATIENTS FROM THE FRENCH OBSERVATIONAL COHORT ANRS CO22 HEPATHER S. Pol; M. Bourliere; S. Lucier; V. De Ledinghen; F. Zoulim; C. Dorival-Mouly; S. Metivier; D. Larrey; A. Tran; C. Hezode; J.P. Bronowicki; D. Samuel; P. Marcellin; J.P. Zarski; A. Minello; L. Alric; J.C. Trinchet; P. Nahon; D. Guyader; O. Chazouilleres; G. Riachi; V. Loustaud-Ratti; X. Causse; P. Mathurin; I. Hubert-Fouchard; I. Rosa; Y. Benhamou; J. Gournay; J.J. Raabe; F. Raffi; V. Petrov-Sanchez; A. Diallo; H. Fontaine; F. Carrat; H.Study Grp 2015 |
10.1016/S0168-8278(15)30149-5 |
|
Safety and efficacy of transcatheter embolization with Glubran (R) 2 cyanoacrylate glue for acute arterial bleeding: a single-center experience with 104 patients G. Abdulmalak; O. Chevallier; N. Falvo; L. Di Marco; A. Bertaut; B. Moulin; C. Abi-Khalil; S. Gehin; P.E. Charles; M. Latournerie; M. Midulla; R. Loffroy 2018 |
10.1007/s00261-017-1267-4 |
|
Safety and Efficacy of Transcatheter Mitral Valve Replacement Guided by Intracardiac Echocardiography T. Pommier; C. Guenancia; A. Sagnard; B. Ferrand; R. Didier; M. Fichot; G. Laurent; M.C. Morgant; O. Bouchot; L. Lorujis 2021 |
10.1016/j.jcin.2021.05.038 |
|
Safety and feasibility of a neuromuscular electrical stimulation chronaxie-based protocol in critical ill patients: A prospective observational study P.Eugenio Silva; N. Babault; J.Batista Mazullo; T.Pereira de Oliveira; B.Leticia Lemos; V.Oliveira Carvalho; J.Luiz Quagl Durigan 2017 |
10.1016/j.jcrc.2016.09.012 |
|
Safety and imaging performance of two-channel RF shimming for fetal MRI at 3T F. Yetisir; E.Abaci Turk; B. Guerin; B.A. Gagoski; E. Grant; E. Adalsteinsson; L.L. Wald 2021 |
10.1002/mrm.28895 |
|
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HBO4 B-BOOST): a multicentre, open-label, randomised controlled trial D. Rey; L. Piroth; M.J. Wendling; P. Miailhes; M.L. Michel; C. Dufour; G. Haour; P. Sogni; A. Rohel; F. Ajana; E. Billaud; J.M. Molina; O. Launay; F. Carrat; A.N.R.S.Hb04 B.Boo Grp 2015 |
10.1016/S1473-3099(15)00220-0 |
|
Safety and Long-Term Efficacy of Maintenance Therapy with Alternating Azacytidine (AZA) and Lenalidomide (Len) Cycles in Elderly (>= 60) Fit Patients (Pts) with Poor Prognosis AML in First Complete Remission (CR) After LIA Induction. A Phase II Multicentr M. Hunault; N. Maillard; A. Tanguy-Schmidt; C. Himberlin; B. Choufi; C. Bonmati; M.Anne Couturier; E. Deconinck; J.Pierre Marolleau; F. Orsini-Piocelle; J. Delaunay; E. Tavernier; C. Recher; S. Lissandre; M. Ojeda-Uribe; L. Sanhes; L. Sutton; A. Banos; B. Lioure; M. Bernard; D. Bouscary; A. Saad; V. Rouille; P. Guardiola; I. Luquet; M.C. Bene; F. Dreyfus; J.Y. Cahn; A. Pigneux; N. Ifrah 2015 |
|
|
Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience J. Blanc; C. Deschasse; L. Kodjikian; C. Dot; A.M. Bron; C. Creuzot-Garcher 2018 |
10.1007/s00417-018-4016-7 |
|
Safety and Predictive Factors of Short-Term Efficacy of a Single Injection of Mannitol-Modified Cross-Linked Hyaluronic Acid in Patients with Trapeziometacarpal Osteoarthritis. Results of a Multicentre Prospective Open-Label Pilot Study (INSTINCT Trial) J. Dauvissat; C. Rizzo; H. Lellouche; J. Porterie; S. Melac-Ducamp; V. Locquet; V. Travers; B. Maillet; T. Conrozier 2018 |
10.1177/1179544118782901 |
|
Safety and tolerability of subcutaneous trastuzumab for HER2-positive early breast cancer in patients with lower body weight and in Asian patients: SafeHer Phase III study subgroup analyses K.H. Jung; B. Ataseven; M. Verrill; M. De Laurentiis; H.A. Azim; X. Pivot; N. Al-Sakaff; S. Lauer; M. Shing; J. Gligorov 2015 |
10.1016/S0959-8049(16)30904-2 |
|
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients J. Gligorov; B. Ataseven; M. Verrill; M. De Laurentiis; K.H. Jung; H.A. Azim; N. Al-Sakaff; S. Lauer; M. Shing; X. Pivot; S.H.Study Grp 2017 |
10.1016/j.ejca.2017.05.010 |
|
Safety assessment of nanoparticles for drug delivery by means of classic in vitro assays and beyond S. Lorscheidt; A. Lamprecht 2016 |
10.1080/17425247.2016.1198773 |
|
Safety case reports analysis of progestin-only contraceptives within the French Pharmacovigilance Database A. Grandvuillemin; A. Boulay; M. Luu; P. Delaunay; A. Gouverneur; J. Benevent; A. Dautriche 2018 |
|
|
Safety case reports analysis of progestin-only contraceptives within the French Pharmacovigilance Database A. Grandvuillemin; A. Boulay; M. Luu; P. Delaunay; A. Gouverneur; J. Benevent; A. Dautriche 2018 |
|
|
Safety of 6000 intravitreal dexamethasone implants B. Rajesh; J. Zarranz-Ventura; A.T. Fung; C. Busch; N.Kumar Sahoo; P.J. Rodriguez-Valdes; V. Sarao; S.Kumar Mishra; O. Saatci; P.Udaondo Mirete; G. Querques; M.Eid Farah; P. Lanzetta; F. Arevalo; L. Kodjikian; J. Chhablani; A. Gupta; A. Singh; A. Goud; A. Mansour; A. Banker; A.C. Sen; A. Marashi; A. Maia; A. Maiti; A. Sala-Puigdollers; A. Sharma; C. Cagini; C. Bernal-Morales; C. Sarvaiya; D. Veritti; D. Zur; D. Masarwa; E. Novais; E. Giancipoli; F. Bandello; H. Al-Khersan; J.S. Wong; K. Raji; L. Wu; M. Okada; M. Nagpal; M. Casella; M. Lupidi; M. Avila; M. Berrocal; M. Iglicki; M. Maia; M. Cavalleri; M.Abdul Rasheed; M. Asencio-Duran; N. Rassu; O. D'Anna-Mardero; P.H. Gabrielle; P. Shenoy; R. Gallego-Pinazo; R.Dolz Marco; S. Kumar; S. Patyal; S. Fraser-Bell; S. Cohen; S.Randhir Singh; V. Sharma; V. Sarao; V. Chaikitmongkol; Z. Cebeci; Z. Ayhan; C. Bernal-Morales; C. Sarvaiya; D. Veritti; D. Zur; D. Masarwa; E. Novais; E. Giancipoli; F. Bandello; H. Al-Khersan; J.S. Wong; K. Raji; L. Wu; M. Okada; M. Nagpal; M. Casella; M. Lupidi; M. Avila; M. Berrocal; M. Iglicki; M. Maia; M. Cavalleri; M.Abdul Rasheed; M. Asencio-Duran; N. Rassu; O. D'Anna-Mardero; P.H. Gabrielle; P. Shenoy; R. Gallego-Pinazo; R.Dolz Marco; S. Kumar; S. Patyal; S. Fraser-Bell; S. Cohen; S.Randhir Singh; V. Sharma; V. Sarao; V. Chaikitmongkol; Z. Cebeci; Z. Ayhan; C. Bernal-Morales; C. Sarvaiya; D. Veritti; D. Zur; D. Masarwa; E. Novais; E. Giancipoli; F. Bandello; H. Al-Khersan; J.S. Wong; K. Raji; L. Wu; M. Okada; M. Nagpal; M. Casella; M. Lupidi; M. Avila; M. Berrocal; M. Iglicki; M. Maia; M. Cavalleri; M.Abdul Rasheed; M. Asencio-Duran; N. Rassu; O. D'Anna-Mardero; P.H. Gabrielle; P. Shenoy; R. Gallego-Pinazo; R.Dolz Marco; S. Kumar; S. Patyal; S. Fraser-Bell; S. Cohen; S.Randhir Singh; V. Sharma; V. Sarao; V. Chaikitmongkol; Z. Cebeci; Z. Ayhan; I.Ozurdex St Grp 2020 |
10.1136/bjophthalmol-2019-313991 |
|
SAFETY OF BEVACIZUMAB CONTAINING NEOADJUVANT THERAPY FOLLOWED BY INTERVAL DEBULKING SURGERY IN ADVANCED OVARIAN CANCER: DATA FROM THE ANTHALYA TRIAL S. Gouy; F. Selle; E. Lanbaudie; F. Guyon; V. Fourchotte; C. Pomel; P.E. Colombo; E. Kalbacher; S. Martin-Francoise; R. Fauvet; P. Follana; A. Lesoin; F. Lecuru; V. Menguy; Y. Ghazi; E. Chereau; S. Zohar; P. Cottu; F. Joly; R. Rouzier 2015 |
|
|
Safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Data from the ANTHALYA trial F. Selle; S. Gouy; E. Lambaudie; F. Guyon; V. Fourchotte; C. Pomel; P.E. Colombo; E. Kalbacher; S. Martin-Francoise; R. Fauvet; P. Follana; A. Lesoin; F. Lecuru; V. Menguy; Y. Ghazi; E. Chereau; S. Zohar; P. Cottu; F. Joly; R. Rouzier 2015 |
10.1016/S0959-8049(16)31532-5 |
|
SAFETY OF BIOLOGIC TREATMENTS IN SOLID ORGAN TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW M. Frederic; W.V. Delphine; C. Prati; D. Wendling; F. Verhoeven 2021 |
10.1136/annrheumdis-2021-eular.1372 |
|
Safety of Dimethylfumarate in clinical practice: a regional study M. Bereau; C. Clerc; A. Jary; A. Lavier; L. Chamard; E. Magnin; E. Berger 2016 |
|
|
Safety of Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Pancreatic Solid Pseudopapillary Neoplasm Before Surgical Resection A European Multicenter Registry-Based Study on 149 Patients D. Karsenti; F. Caillol; U. Chaput; B. Perrot; S. Koch; L. Vuitton; J. Jacques; J.C. Valats; L. Poincloux; C. Subtil; E. Chabrun; N. Williet; G. Vanbiervliet; H. Belkhodja; A. Charachon; M. Wangermez; E. Coron; F. Cholet; J. Privat; Y. Le Baleur; P. Bichard; P.Ah Soune; S. Lecleire; M. Palazzo; GRAPHE 2020 |
10.1097/MPA.0000000000001460 |
|
Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNF alpha agents: a French nationwide population-based cohort M. Luu; E. Benzenine; A. Barkun; M. Doret; C. Michiels; T. Degand; C. Quantin; M. Bardou 2019 |
10.1111/apt.15504, Early Access Date = {OCT 2019 |
|
Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNF alpha agents: a French nationwide population-based cohort M. Luu; E. Benzenine; A. Barkun; M. Doret; C. Michiels; T. Degand; C. Quantin; M. Bardou 2019 |
10.1111/apt.15504 |
|
Safety of Immune Checkpoint Inhibitors for the Treatment of Melanoma, Bronchopulmonary and Urologic Neoplasms in Patients with Preexisting Autoimmune Disease A. Tison; G. Quere; L. Misery; T. Lesimple; M. Marcq; S. Martinez; F. Brunet-Possenti; S. Mansard; N. Beneton; M. Lambert; C. Roge; O. Zehou; F. Aubin; S. Maanaoui; C. Scalbert; D. Giacchero; N. Kramkimel; F. Skowron; A. Pham-Ledard; D. Cornec; M. Kostine 2017 |
|
|
Safety of Immune Checkpoint Inhibitors in Patients with Preexisting Autoimmune Disease A. Tison; G. Quere; L. Misery; M. Geier; T. Lesimple; M. Marcq; S. Martinez; F. Brunet-Possenti; S. Mansard; N. Beneton; M. Lambert; C. Roge; O. Zehou; F. Aubin; S. Maanaoui; C. Scalbert; D. Giacchero; N. Kramkimel; F. Skowron; A. Pham-Ledard; D. Cornec; M. Kostine 2017 |
10.1016/j.jtho.2017.11.082 |